Antibody responses to common viruses according to COVID‐19 severity and postacute sequelae of COVID‐19
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Marianna Karachaliou und 14 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Barcelona, Spain. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, Immunoglobulin G. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RYC 2020-029886 I/ AEI/10.13039/501100011033, Fundació Privada Daniel Bravo Andreu, Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA).
Abstract (Originalsprache)
Limited research suggests that certain viruses reactivate in severe‐acute‐respiratory‐syndrome‐coronavirus 2 infection, contributing to the development of postacute sequelae of COVID‐19 (PASC). We examined 1083 infected individuals from a population‐based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein‐Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv‐36 according to the severity of previous COVID‐19 and PASC history. Individuals who had experienced severe COVID‐19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen‐diffuse, VZV, and WUPyV even among individuals without previous severe COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ISGlobal, Barcelona, Spain.
- CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
- Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
- IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
- Genomes for Life-GCAT Lab, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
- Banc de Sang i Teixits (BST), Barcelona, Spain.
ORCID-Profile: Marianna Karachaliou, Carlota Dobaño
Förderung
- RYC 2020-029886 I/ AEI/10.13039/501100011033
- Fundació Privada Daniel Bravo Andreu
- Generalitat de Catalunya through the Centres de Recerca de Catalunya (CERCA)
- END-VOC Project (Horizon 2021-2024)
- Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa 2019-2023 programme (CEX2018-000806-S)
- Acción de Dinamización del ISCIII-MINECO
- Ministry of Health of the Generalitat of Catalunya
- Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
Zitieren
APA
Karachaliou, M., Ranzani, O., Espinosa, A., Iraola-Guzmán, S., Castaño-Vinyals, G., Vidal, M., Jiménez, A., Bañuls, M., Nogués, E. A., Aguilar, R., Garcia-Aymerich, J., de Cid, R., Dobaño, C., Moncunill, G., & Kogevinas, M. (2024). Antibody responses to common viruses according to COVID‐19 severity and postacute sequelae of COVID‐19. Journal of Medical Virology. https://doi.org/10.1002/jmv.29862
Vancouver
Karachaliou M, Ranzani O, Espinosa A, Iraola-Guzmán S, Castaño-Vinyals G, Vidal M, et al. Antibody responses to common viruses according to COVID‐19 severity and postacute sequelae of COVID‐19. Journal of Medical Virology. 2024. doi:10.1002/jmv.29862
BibTeX
@article{Karachaliou2024,
author = {Karachaliou, Marianna and Ranzani, Otavio and Espinosa, Ana and Iraola-Guzmán, Susana and Castaño-Vinyals, Gemma and Vidal, Marta and Jiménez, Alfons and Bañuls, Marc and Nogués, Eva Alonso and Aguilar, Ruth and Garcia-Aymerich, Judith and de Cid, Rafael and Dobaño, Carlota and Moncunill, Gemma and Kogevinas, Manolis},
title = {Antibody responses to common viruses according to COVID‐19 severity and postacute sequelae of COVID‐19},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29862}
}
EUVIMED